Jove
Visualize
お問い合わせ

関連する概念動画

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

269
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
269
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Diagnostic Accuracy of AI-Assisted Focused Cardiac Ultrasound (FOCUS) in Primary Care.

Healthcare (Basel, Switzerland)·2025
Same author

Continuous Laser Versus Micropulse Laser in the Treatment of Central Serous Chorioretinopathy: A Retrospective Study.

Cureus·2024
Same author

Sociodemographic, cultural, linguistic, and test selection considerations for clinical neuropsychological assessment with Japanese and Japanese-American patients in the United States.

The Clinical neuropsychologist·2023
Same author

Corrigendum to Diversity and disparities in research studies and career trajectories in Psychiatry, Psychiatry Research, Volume 308, February 2022, 114333.

Psychiatry research·2022
Same author

Diversity and disparities in research studies and career trajectories in psychiatry.

Psychiatry research·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

薬物開発

Sayaka Machizawa1, Gila Barbati1, Madison Soleil DeCapo1

  • 1Signant Health, Blue Bell, PA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
まとめ

アルツハイマー病の臨床試験では、ミニメンタルステート検査(MMSE)の実施と採点の誤りが一般的です。評価者のトレーニングを改善し、データ品質監視を実施することで、データの精度を向上させることができます。

科学分野:

  • 神経学
  • 臨床試験
  • 認知評価

背景:

  • ミニメンタルステート検査(MMSE)は、臨床研究で広く使用されている認知評価ツールです。
  • その普及にもかかわらず、実施および採点エラーが頻繁に観察されています。
  • これらのエラーは、ガイドラインの一貫性の欠如、評価者の経験、および基準の適用から生じます。

研究 の 目的:

  • MMSEにおける一般的な実施および採点エラーを特定し、調査すること。
  • 多国籍アルツハイマー病臨床試験におけるサイト評価者の間でこれらのエラーを調査すること。

主な方法:

  • 2つの多国籍第3相アルツハイマー病試験からのMMSE評価の中央レビューが実施されました。
  • 訓練を受けた中央レビュー担当者が、事前に定義されたフラグを使用してMMSEスクリーニングの音声とデータを分析し、エラーを特定しました。
  • エラー頻度は、研究全体で一貫したトレーニングとフラグセットに基づいて計算されました。

主要な成果:

  • 10,000件以上のMMSE評価がレビューされ、約27%が実施エラー、27%が採点エラーとしてフラグが立てられました。
  • 最も頻繁に見られたエラーは、場所の見当識における実施と採点の問題、および注意と計算、時間の見当識、書字における実施エラーでした。
キーワード:
アルツハイマー病臨床試験ミニメンタルステート検査評価者トレーニングデータ品質

さらに関連する動画

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446

関連する実験動画

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446
  • これらの一般的なエラーの詳細な頻度を示します。
  • 結論:

    • ミニメンタルステート検査(MMSE)は、臨床試験において一般的な実施および採点エラーを示します。
    • 標準化されていない慣行は、データのばらつきを導入し、研究結果に影響を与える可能性があります。
    • データの精度と信頼性を向上させるためには、堅牢なデータ品質監視、中央レビュー、および評価者のトレーニングの強化を実施することが不可欠です。